Who are Yellow fever vaccine (live)'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Bacille Calmette Guerin (BCG), Yellow fever vaccine, Institut Pasteur, Rotarix (RV1), RotaTeq™ (V260), Live Attenuated H1N1 Influenza Vaccine, BCG Solution.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/yellow-fever-vaccine-live.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Yellow fever vaccine (live) — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Yellow fever vaccine (live) (Yellow fever vaccine (live)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: live attenuated vaccine. Area: Immunology.

phase 3 live attenuated vaccine Immunology Biologic Live · refreshed every 30 min

Target snapshot

Yellow fever vaccine (live) (Yellow fever vaccine (live)) — Sanofi Pasteur, a Sanofi Company. The live yellow fever vaccine stimulates an immune response by introducing a weakened form of the yellow fever virus, allowing the body to develop immunity.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Yellow fever vaccine (live) TARGET	Yellow fever vaccine (live)	Sanofi Pasteur, a Sanofi Company	phase 3	live attenuated vaccine
Bacille Calmette Guerin (BCG)	Bacille Calmette Guerin (BCG)	Bandim Health Project	marketed	Live attenuated vaccine
Yellow fever vaccine, Institut Pasteur	Yellow fever vaccine, Institut Pasteur	University of Oxford	marketed	Live attenuated vaccine
Rotarix (RV1)	Rotarix (RV1)	Telethon Kids Institute	marketed	Live attenuated vaccine	Rotavirus VP4 and VP7 surface proteins
RotaTeq™ (V260)	RotaTeq™ (V260)	Merck Sharp & Dohme LLC	marketed	Live attenuated vaccine
Live Attenuated H1N1 Influenza Vaccine	Live Attenuated H1N1 Influenza Vaccine	University of Rochester	marketed	Live attenuated vaccine
BCG Solution	BCG Solution	Alliance for Clinical Trials in Oncology	marketed	Live attenuated vaccine / Immunotherapy

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (live attenuated vaccine class)

GlaxoSmithKline · 2 drugs in this class
Centers for Disease Control and Prevention · 1 drug in this class
MedImmune LLC · 1 drug in this class
Sanofi Pasteur, a Sanofi Company · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Yellow fever vaccine (live) — Competitive Intelligence Brief. https://druglandscape.com/ci/yellow-fever-vaccine-live. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab